Participation in the SUCCESSA trial improves intensity and quality of care for patients with primary breast cancer;Teilnahme an der SUCCESSA-Studie verbessert Intensität und Qualität der medizinischen Betreuung bei Patientinnen mit primärem Mammakarzinom

Tumor Diagnostik und Therapie

Volumn 34, Issue 3, 2013, Pages 140-146

  Andergassen, U ^a   Kasprowicz, N S ^b   Hepp, P ^b   Schindlbeck, C ^c   Harbeck, N ^a   Kiechle, M ^d   Sommer, H ^a   Beckmann, M W ^e   Friese, K ^a   Janni, W ^f   Rack, B ^a   Scholz, C ^f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Klinikum Traunstein   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

biomarker; breast cancer; gynecology

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; ZOLEDRONIC ACID;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PATIENT CARE; PRIMARY TUMOR; QUESTIONNAIRE;

EID: 84876562910     PISSN: 0722219X     EISSN: 14391279     Source Type: Journal    
DOI: 10.1055/s-0033-1335209     Document Type: Article

References (20)

1. Peto R., Boreham J., Clarke M. et al. UK and USA breast cancer deaths down 25 % in year 2000 at ages 20 - 69 years. Lancet: 2000; 355 1822 (Pubitemid 30265099)
2. Melcher C., Scholz C., Jäger B. et al. Breast cancer: state of the art and new findings. Geburtsh Frauenheilk: 2012; 72 215 224
3. Grand M. M., O'Brien P. C. Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature. J Med Imaging Radiat Oncol: 2012; 56 31 39
4. Lamunu D., Chapman K. N., Nsubuga P. et al. Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment. Int J Tuberc Lung Dis: 2012; 16 480 485
5. Ezeugwu C. O., Laird A., Mullins C. D. et al. Lessons learned from community-based minority health care serving system participation in an NIH clinical trial. J Natl Med Assoc: 2011; 103 839 844
6. Goyal J., Nuhn P., Huang P. et al. The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer. BJU Int: 2012; 10.1111/j.1464-410X.2012.11286.x
7. Kümmel S., Kolberg H. C., Lüftner D. et al. Mammakarzinom 2011 - Neue Aspekte. Geburtsh Frauenheilk: 2011; 71 939 953
8. Janni W., Salmem J. Mammakarzinom: Was bringt die SUCCESS-Studie Neues? Geburtsh Frauenheilk: 2010; 70 330 331
9. Hartkopf A. D., Banys M., Krawczyk N. et al. Circulating tumor cells in early-stage breast cancer. Geburtsh Frauenheilk: 2011; 71 1067 1072
10. Lawton J., Jenkins N., Darbyshire J. et al. Understanding the outcomes of multi-centre clinical trials: a qualitative study of health professional experiences and views. Soc Sci Med: 2012; 74 574 581
11. Janni W., Kiechle M., Sommer H. et al. Study participation improves treatment strategies and individual patient care in participating centers. Anticancer Res: 2006; 26 3661 3667 (Pubitemid 44701440)
12. Rack B., Juckstock J., Genss E. M. et al. Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer. Anticancer Res: 2010; 30 1807 1813
13. Goldhirsch A., Glick J., Gelber R. et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol: 2005; 16 1569 1583 (Pubitemid 41511089)
14. Goldhirsch A., Wood W., Gelber R. et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol: 2007; 18 113 144
15. Schindowski D. Optimierte Studiendurchführung zur Steigerung der Anzahl von Studienpatientinnen an Brustzentren. Senologie - Zeitschrift für Mammadiagnostik und therapie: 2009; 6 A101
16. Hebert-Croteau N., Brisson J., Lemaire J. et al. The benefit of participating to clinical research. Breast Cancer Res Treat: 2005; 91 279 281 (Pubitemid 40896573)
17. Lüftner D., Lux M. P., Maass N. et al. Advances in breast cancer - looking back over the year. Geburtsh Frauenheilk: 2012; 72 1117 1129
18. Schmidt M., Fasching P. A., Beckmann M. W. et al. Biomarkers in breast cancer - an update. Geburtsh Frauenheilk: 2012; 72 819 832
19. Dieterich M., Dieterich H., Moch H. et al. Re-excision rates and local recurrence in breast cancer patients undergoing breast conserving therapy. Geburtsh Frauenheilk: 2012; 72 1018 1023
20. Rhiem K., Pfeifer K., Schmutzler R. K. et al. Risk-reducing surgery in women at risk for familial breast or ovarian cancer. Geburtsh Frauenheilk: 2012; 72 833 839